host
cell
respons
pathogen
virus
commonli
mediat
phosphorylationregul
signal
pathway
affect
exampl
chang
gene
express
pattern
signal
process
initi
cell
defens
viral
pathogen
also
use
viru
support
replic
interact
viral
surfac
protein
host
cellular
surfac
shown
initi
cellular
reaction
lead
first
wave
cytokin
product
interleukin
il
tumor
necrosi
interferon
ifn
antiinflammatori
cytokin
pleiotrop
cytokin
play
import
role
regul
lymphoid
myeloid
cell
function
due
abil
block
cytokin
synthesi
sever
accessori
cell
function
macrophag
potent
suppressor
effector
function
macrophag
cell
nk
cell
mani
virus
well
sever
viral
envelop
particl
induc
activ
innat
host
defens
pathway
result
product
type
ifn
among
particular
induct
gene
express
tightli
regul
process
previou
studi
identifi
signal
transduct
pathway
tankbind
ifn
regulatori
essenti
activ
gene
express
addit
activ
effici
induct
usual
requir
activ
nuclear
transcript
transcript
suggest
essenti
compon
innat
immun
respons
viru
infect
activ
transcript
factor
belong
larg
famili
structur
relat
transcript
factor
includ
cfo
cjun
cmyc
consist
variou
combin
fo
jun
famili
member
ie
cfo
fosb
cjun
junb
jund
dimer
via
leucin
zipper
domain
bind
dna
via
specif
target
dna
sequenc
particular
transcript
factor
becom
activ
tyrosin
serinethreonin
phosphoryl
involv
primarili
nonreceptor
protein
tyrosin
kinas
ntptk
protein
kinas
c
pkc
janusactiv
kinas
jak
initi
downstream
signal
cascad
mitogenactiv
protein
kinas
mapk
phosphatidylinositol
regul
sever
respons
includ
mitosi
apoptosi
motil
prolifer
differenti
mani
other
surpris
therefor
mani
virus
target
mapk
pathway
mean
manipul
cellular
function
four
differ
member
mapk
famili
organ
separ
cascad
identifi
date
three
extracellularsignalregul
kinas
erk
jun
ntermin
kinas
jnk
report
activ
upon
viral
infect
erk
activ
mani
virus
includ
hcmv
kaposi
sarcomaassoci
herpesviru
kshv
hepat
b
c
virus
papilloma
viru
adenoviru
influenza
viru
respiratori
syncyti
viru
rsv
human
immunodefici
viru
hiv
mapk
activ
document
infect
rhinoviru
herpesvirus
hiv
adenoviru
influenza
viru
hepat
b
viru
mani
envelop
virus
trigger
upon
bind
specif
cellular
receptor
fusion
reaction
viral
envelop
cell
membran
process
involv
structur
modif
exposur
small
stretch
hydrophob
amino
acid
fusion
reaction
direct
fusion
protein
undergo
consist
structur
modif
lead
exposur
small
stretch
hydrophob
aminoacid
fusion
peptid
interact
oppos
lipid
bilay
involv
initi
stage
viru
penetr
three
class
fusion
protein
identifi
far
class
compris
mani
unrel
viru
famili
paramyxovirus
orthomyxovirus
retrovirus
filovirus
class
ii
appli
flavivirida
famili
compris
tickborn
enceph
viru
tbe
dengu
viru
yellow
fever
viru
west
nile
viru
hepat
c
viru
togavirida
famili
best
known
semliki
forest
viru
rubella
viru
class
iii
fusion
protein
compris
rhabdovirus
herpesvirus
studi
effect
bind
cell
surfac
peptid
known
fusogen
activ
activ
signal
pathway
examin
set
known
fusion
peptid
differ
viru
famili
synthes
activ
sever
signal
transduct
pathway
investig
monocyt
atcc
cultur
rpmi
gibco
heatinactiv
fetal
calf
serum
glutamin
mm
penicillin
uml
streptomycin
uml
differenti
previous
describ
treatment
cell
serum
concentr
reduc
h
reduc
serumfre
media
least
h
prevent
interfer
serum
factor
phosphoryl
state
protein
signal
cascad
fusion
peptid
correspond
set
differ
virus
prepar
standard
polyamin
solidphas
synthes
use
multispecif
peptid
synthes
shimadzu
corpor
biotechnolog
instrument
depart
kyoto
japan
tga
resin
substitut
mmolg
use
solidphas
support
synthes
perform
scale
amino
acid
equival
rel
resin
load
coupl
accord
tbtuhobtdiea
method
equival
fmocamino
acid
equival
tbtu
equival
hobt
hobt
dmf
equival
diea
diea
dmf
fmocprotect
group
remov
piperidin
dmf
vv
peptid
fulli
deprotect
cleav
resin
hydrofluor
acid
treatment
tfa
solut
contain
thioanisol
ethandithiol
anisol
scaveng
crude
peptid
precipit
icecold
ethyl
ether
filter
redissolv
water
lyophilis
crude
peptid
purifi
homogen
prepar
reversephas
highpressur
liquid
chromatographi
hplc
water
delta
prep
chromatograph
system
equip
uv
lambda
max
mod
detector
sampl
inject
jupit
phenomenex
column
mm
cm
elut
tfa
tfa
b
solvent
mixtur
linear
gradient
b
min
flow
rate
ml
employ
collect
fraction
lyophilis
dryness
analyz
analyt
reversephas
hplc
shimadzu
equip
diod
array
detector
use
phenomenex
analyt
column
mm
linear
gradient
b
min
flow
rate
mlmin
use
ident
purifi
peptid
confirm
maldi
spectrometri
purifi
peptid
obtain
high
yield
scrambl
peptid
fusion
peptid
also
synthes
control
evalu
sequenc
depend
result
tabl
show
sequenc
synthes
peptid
peptid
detoxifi
test
cell
detoxif
perform
use
detoxi
gel
affin
pak
column
suppli
pierc
rockford
ill
usa
peptid
use
stimul
cell
vitro
analyz
phosphoryl
pattern
signal
pathway
cell
cellsml
stimul
fusion
peptid
concentr
compris
differ
time
point
time
point
concentr
determin
preliminari
experi
analysi
test
peptid
min
incub
cell
wash
twice
icecold
pb
without
resuspend
appropri
kinas
lysi
buffer
lysat
transfer
icecold
microcentrifug
tube
vortex
incub
min
ice
centrifug
g
min
remov
insolubl
compon
cell
lysat
preclear
protein
ag
plusagaros
santa
cruz
biotechnolog
inc
calif
usa
min
immunoprecipit
done
appropri
antibodi
bead
overnight
gentl
rotat
incub
bead
pellet
g
wash
three
time
specif
lysi
buffer
boil
laemmli
sampl
buffer
min
lysat
sampl
contain
protein
separ
sd
page
gel
describ
laemmli
follow
electrophoresi
separ
gel
soak
transfer
buffer
mm
tri
mm
glycin
methanol
min
protein
transfer
polyvinyliden
difluorid
membran
pore
size
overnight
v
blot
block
h
room
temperatur
trisbuff
salin
tb
mm
nacl
mm
trishcl
ph
contain
bovin
serum
albumin
bsa
plu
blottinggrad
blocker
nonfat
milk
biorad
laboratori
subsequ
membran
wash
twice
tb
contain
tween
ttb
incub
antiphosphoryl
kinas
antibodi
dilut
tb
contain
bsa
h
room
temperatur
wash
six
time
ttb
min
polyvinyliden
difluorid
membran
incub
room
temperatur
h
specif
immunoglobulin
g
igg
horseradish
peroxidas
secondari
antibodi
dilut
wash
six
time
ttb
twice
pb
min
thereaft
protein
visual
enhanc
chemiluminesc
kodak
xomat
ls
film
immunoprecipit
western
blot
carri
use
phosphospecif
antibodi
follow
antiphosphopkc
antibodi
detect
endogen
level
pkc
isoform
phosphoryl
residu
homolog
human
cell
signal
technolog
inc
antiphosphosrc
famili
antibodi
recogn
synthet
phosphopeptid
correspond
residu
surround
human
src
cell
signal
technolog
inc
antiphosphoakt
recogn
phosphoryl
cell
signal
technolog
inc
mous
monoclon
antibodi
rais
cell
signal
technolog
inc
antibodi
santa
cruz
biotechnolog
inc
rabbit
polyclon
antibodi
rais
peptid
map
amino
terminu
mous
origin
ident
correspond
human
sequenc
direct
santa
cruz
biotechnolog
inc
antiphosphojnk
antibodi
mous
monoclon
antibodi
rais
peptid
correspond
short
amino
acid
sequenc
phosphoryl
jnk
human
origin
santa
cruz
biotechnolog
inc
assay
carri
use
cell
cellsml
stimul
viral
fusion
peptid
incub
h
incub
sampl
centrifug
rpm
min
supernat
collect
store
sampl
assay
presenc
elisa
accord
manufactur
instruct
use
human
elisa
kit
pbl
biomed
laboratori
human
elisa
kit
bender
medsystem
standard
sampl
dilut
perform
least
four
time
individu
cellstimul
assay
detect
quantifi
activ
cell
use
elisabas
transam
transcript
factor
kit
activ
motif
carlsbad
calif
usa
accord
manufactur
recommend
protein
ad
well
plate
coat
immobil
oligonucleotid
contain
tparespons
element
tre
consensu
site
accord
transcript
factor
analyz
incub
period
room
temperatur
well
wash
time
wash
buffer
includ
kit
provid
anti
cfo
anti
cjun
antibodi
ad
dilut
plate
incub
room
temperatur
h
well
wash
time
hrpconjug
antirabbit
igg
ad
dilut
incub
h
room
temperatur
cell
wash
time
develop
solut
ad
follow
stop
solut
amount
activ
measur
nm
ht
bioassay
reader
perkin
elmer
norwalk
colo
usa
preliminari
experi
transam
kit
show
good
correl
emsa
detect
dna
bind
capac
optim
time
stimul
h
peptid
concentr
use
elisa
determin
pilot
assay
lactat
dehydrogenas
ldh
assay
carri
accord
manufactur
instruct
use
cytotox
detect
kit
roch
diagnost
gmbh
roch
molecular
biochem
ldh
stabl
cytoplasm
enzym
present
cell
rapidli
releas
cell
cultur
supernat
plasma
membran
damag
ldh
activ
determin
coupl
enzymat
reaction
wherebi
tetrazolium
salt
int
reduc
formazan
increas
number
dead
damag
cell
result
increas
ldh
activ
cultur
supernat
amount
ldh
show
treat
untreat
cell
healthi
solut
peptid
prepar
use
experi
test
presenc
endotoxin
use
limulu
amoebocyt
lysat
lal
gelclot
assay
associ
cape
cod
inc
distribut
pbi
intern
milan
itali
describ
yin
et
al
lower
detect
limit
assay
iuml
gel
scan
densitometri
analysi
sigma
gel
softwar
result
shown
averag
triplic
experi
result
express
mean
valu
se
three
independ
observ
specif
ligandreceptor
interact
result
activ
signal
pathway
thu
select
fusion
peptid
belong
known
viral
class
fusion
glycoprotein
order
verifi
whether
interact
cell
surfac
suffici
induc
phosphoryl
pkc
src
akt
mapk
pathway
activ
nuclear
factor
cytokin
releas
address
question
synthes
fusion
peptid
sever
virus
alreadi
identifi
sequenc
report
tabl
experi
test
scrambl
sequenc
fusion
peptid
scrambl
lipopolysaccharid
lp
escherichia
coli
sigma
st
loui
mo
usa
order
verifi
reliabl
experi
demonstr
activ
signal
transduct
pathway
cytokin
releas
induct
activ
sequenc
addit
peptid
deriv
porin
haemophilu
influenza
type
b
peptid
peptid
deriv
nonfus
viral
glycoprotein
name
sendai
viru
glycoprotein
hn
peptid
nonfp
includ
studi
use
lal
test
endotoxin
level
cell
cultur
peptid
solut
result
lower
iuml
data
shown
order
investig
peptideinduc
protein
phosphoryl
wholecel
lysat
cell
assay
immunoprecipit
phosphoryl
protein
follow
western
blot
analysi
determin
dose
respons
kinet
cell
cellswel
treat
peptid
concentr
compris
differ
time
period
min
durat
treatment
peptid
concentr
use
toxic
cell
fact
treatment
induc
signific
releas
ldh
cell
supernat
data
shown
concentr
still
toxic
cell
verifi
ldh
releas
increas
enzym
phosphoryl
pkc
activ
earli
marker
cell
respons
interact
extern
molecul
assay
pkc
phosphoryl
cell
treatment
viral
fusion
peptid
fusion
peptid
studi
induc
rapid
pkc
phosphoryl
earli
min
treatment
follow
phosphoryl
statu
pkc
min
data
shown
treatment
found
respons
reach
maximum
min
next
examin
pkc
phosphoryl
differ
peptid
concentr
data
shown
doserespons
experi
show
optim
peptid
concentr
induc
kinas
phosphoryl
result
data
shown
standard
concentr
stimul
time
min
chosen
subsequ
experi
fig
b
observ
pkc
phosphoryl
induc
almost
peptid
except
fpvsv
fpsev
caus
signific
increas
moreov
signific
phosphoryl
akt
pkb
evid
treatment
fpsev
fpmev
fpndv
fprsv
fpsfv
assess
eventu
activ
ntptk
cascad
consequ
interact
fusion
peptid
lipid
domain
cell
surfac
assay
src
phosphoryl
shown
figur
src
significantli
activ
fpmev
fprsv
fpiv
fpebov
mainli
fpsfv
fptbev
fpmev
determin
involv
mapk
cascad
perform
kinas
assay
use
cell
lysat
upon
fusion
peptid
treatment
result
indic
activ
kinas
peptid
except
fpvsv
strongli
increas
phosphoryl
particular
fpndv
fpiv
fpebov
caus
activ
higher
control
fig
moreov
shown
figur
jnk
slightli
activ
test
peptid
fprsv
result
activ
higher
control
similar
assay
determin
activ
indic
chang
level
phosphoryl
result
peptid
stimul
fig
select
analyz
regul
virusinduc
activ
elisabas
transam
technolog
nuclear
lysat
cell
stimul
viral
fusion
peptid
perform
transcript
factor
suppos
involv
express
proinflammatori
cytokin
gene
therefor
order
demonstr
activ
investig
fusion
peptid
induct
cfoscjun
subunit
subunit
wholecel
extract
use
ab
specif
epitop
access
nuclear
factor
phosphoryl
bound
target
dna
follow
treatment
cell
synthes
viral
fusion
peptid
bind
significantli
increas
min
maintain
level
min
return
background
level
min
data
shown
particular
found
peptid
abl
activ
significantli
fig
fig
supernat
viral
fusion
peptid
stimul
cell
collect
h
measur
elisa
figur
report
data
obtain
use
cell
cellsml
stimul
concentr
peptid
result
obtain
show
peptid
abl
induc
signific
releas
concentr
peptid
use
well
durat
treatment
toxic
cell
fact
treatment
induc
signific
releas
ldh
cell
supernat
among
first
consequ
viral
bind
surfac
receptor
chang
structur
mani
viru
particl
mani
envelop
virus
includ
retrovirus
herpesvirus
receptor
bind
trigger
fusion
reaction
viral
membran
plasma
membran
virus
includ
influenza
viru
vesicular
stomat
viru
semliki
forest
viru
penetr
start
fusion
viral
membran
cellular
endosom
upon
exposur
low
ph
consequ
fusion
glycoprotein
undergo
consist
structur
modif
lead
exposur
small
stretch
aminoacid
fusion
peptid
interact
oppos
lipid
bilay
initi
fusion
reaction
knowledg
present
studi
first
one
address
role
fusion
peptid
complex
event
signal
activ
viral
infect
analysi
role
play
fusion
peptid
differ
viru
famili
may
also
help
understand
complex
mechan
viral
entri
experiment
result
demonstr
hydrophob
domain
fusion
protein
abl
induc
sever
transduct
pathway
cytokin
product
earliest
event
viral
life
cycl
activ
pathway
seem
directli
relat
sequenc
conform
viral
fusion
peptid
fact
hivscrambl
peptid
induc
activ
analyz
pathway
sever
viral
protein
hepat
b
viru
hbx
epsteinbarr
viru
latent
membran
hcmv
pk
sar
coronaviru
nucleocapsid
protein
shown
activ
also
express
singl
viral
protein
suffici
activ
seen
tax
adenoviru
hbx
hepat
b
viru
howev
underli
molecular
mechan
appear
differ
among
henc
previou
work
signal
cascad
viral
entri
mainli
focus
either
whole
virus
viral
protein
pleschka
show
sever
human
pathogen
rna
virus
includ
influenza
ebola
hepat
c
sar
corona
viru
induc
rafmekerk
signal
transduct
cascad
erk
pathway
activ
requir
differ
level
hiv
infect
well
rsvinduc
earli
gene
express
monick
et
al
report
rsv
infect
caus
two
separ
peak
erk
activ
immedi
follow
viral
bind
min
later
activ
viral
replic
h
match
activ
multipl
pkc
isoform
among
kinas
pkc
superfamili
respons
divers
regulatori
role
mani
cellular
process
also
implic
viru
entri
fact
entri
sever
envelop
virus
includ
rhabdovirus
alphavirus
herpesvirus
influenza
viru
requir
pkc
activ
upon
bind
host
cell
surfac
receptor
taken
togeth
literatur
data
highlight
role
pkc
erk
pathway
effici
infect
replic
certain
viral
speci
consist
result
report
studi
fusion
peptid
result
show
immedi
follow
treatment
cell
peptid
class
fphiv
fpsev
fpmev
fpndv
fprsv
fpiv
fpebov
class
ii
fpsfv
fptbev
pkc
activ
moreov
class
peptid
also
induc
activ
jnk
result
show
none
peptid
abl
induc
activ
moreov
fusion
peptid
class
ii
abl
induc
activ
particular
peptid
abl
activ
significantli
cfo
less
significantli
cjun
though
predomin
mechan
activ
transcript
factor
usual
phosphoryl
cjun
jnk
recent
erk
also
shown
phosphoryl
cfo
therebi
activ
peptid
significantli
activ
src
signal
pathway
src
famili
kinas
protooncogen
enzym
initi
character
context
cell
growth
differenti
activ
src
result
activ
downstream
cellular
target
physiolog
effect
higher
activ
demonstr
cell
accord
investig
shown
activ
mapk
cell
follow
srcdepend
pathway
akt
affect
multipl
cellular
target
increas
metabol
growth
synthet
process
prolifer
suppress
apoptosi
process
benefici
viral
lytic
replic
thu
surpris
virus
develop
mean
activ
akt
lytic
infect
sun
et
al
recent
report
akt
activ
requir
optim
replic
paramyxoviru
nonsegment
negativestrand
virus
moreov
akt
demonstr
play
fundament
role
also
virus
herpesvirus
adenovirus
polyomavirus
poxvirus
result
show
akt
phosphoryl
evid
follow
treatment
fpmev
fpndv
fprsv
fusion
peptid
member
paramyxovirida
famili
particularli
interest
appear
result
obtain
segment
vsv
glycoprotein
g
characterist
class
iii
fusion
protein
peptid
abl
induc
significantli
activ
kinas
studi
although
abl
induc
releas
cytokin
fpvsv
correspond
one
two
predict
fusion
loop
vsv
glycoprotein
g
resolut
crystal
structur
protein
resembl
structur
glycoprotein
b
point
possibl
cooper
two
nonconsecut
segment
tip
rel
loop
order
induc
lipid
destabil
event
membran
fusion
class
iii
fusion
protein
seem
oper
differ
mechan
two
therefor
interest
observ
cytokin
product
obtain
differ
signal
pathway
result
strongli
suggest
analyz
fusion
peptid
activ
signal
cascad
lead
activ
differ
compon
regul
transcript
factor
well
establish
transcript
factor
hallmark
infect
includ
viral
infect
play
central
role
virusdepend
cytokin
express
patholog
thu
releas
follow
treatment
cell
peptid
also
analyz
result
demonstr
cytokin
significantli
releas
stimul
select
peptid
data
report
show
presenc
strong
correl
fusion
peptid
activ
signal
pathway
releas
cytokin
support
fundament
role
play
fusion
peptid
viral
infect
